✦ LIBER ✦

Lack of correlation betweenc-erbB-2 overexpression and the effect of dose-intensification of adjuvant chemotherapy in high-risk breast cancer patients

✍ Scribed by C. Thomssen; M. Untch; G. Konecny; A. Lebeau; P. Dettmar; D. Sattler; W. Kuhn; S. Kahlert; H. Hepp; H. Graeff; F. Jänicke

Book ID: 117666245
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 158 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80125-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of P53 and BCL-2 in high-risk breas

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

✍ Marcella Mottolese; Maria Benevolo; Girolamo Del Monte; Simonetta Buglioni; Paol 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Expression of C-erbB-2/HER-2 in patients

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

✍ Bewick, M; Chadderton, T; Conlon, M; Lafrenie, R; Morris, D; Stewart, D; Glück, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Effects of dose-intensive chemotherapy a

Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients

✍ K. Sundby Hall; T. Wiklund; B. Erikstein; H. Holte; G. Kvalheim; H. Heen Sommer; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 117 KB

Evaluation of the prognostic value of HE

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen

Prognostic significance of the immunocyt

Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation

✍ Solano, C; Badia, B; Lluch, A; Marugan, I; Benet, I; Arbona, C; Prosper, F; Garc 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB